If the (H1N1)v strain mutates, will Pandemrix Pandemic Influenza vaccine (H1N1)vstill be effective?
There are currently no data available to show that Pandemrix Pandemic Influenza vaccine (H1N1)v provides cross-protection against drifted strains of the H1N1 virus. Based on clinical trial results from the H5N1 pandemic influenza vaccine, there is however a possibility that some cross-protection would exist. GSK will evaluate the cross-immunogenic property of Pandemrix Pandemic Influenza vaccine (H1N1)v. Pandemrix , Fluarix and Prepandrix are trademarks of the GlaxoSmithKline group of companies.
Related Questions
- What is the composition of Pandemrix suspension and emulsion for emulsion for injection Pandemic Influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)?
- What is the difference between the seasonal influenza vaccine and the pandemic vaccine against influenza A (H1N1)v?
- What is the indication for Pandemrix Pandemic Influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)?
